Drugs / Chondroitin Sulfate Sodium
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05632783 | Dec 2023 → Dec 2025 | osteoarthritis, knee | IBSA Institut Biochimique SA | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chondroitin Sulfate Sodium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05632783 ↗ |
| Known as | Chondroitin sulfate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108922 ↗ |
| Route | Oral | “chondroitin sulfate 800 mg oral tablets” NCT05632783 ↗ |